These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31917124)

  • 1. Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases.
    Ait-Oufella H; Libby P; Tedgui A
    Arch Cardiovasc Dis; 2020 Jan; 113(1):5-8. PubMed ID: 31917124
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting inflammation: impact on atherothrombosis.
    Marini MG; Sonnino C; Previtero M; Biasucci LM
    J Cardiovasc Transl Res; 2014 Feb; 7(1):9-18. PubMed ID: 24327329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for the prevention of atherosclerotic cardiovascular disease: Promise and possibilities.
    Khambhati J; Engels M; Allard-Ratick M; Sandesara PB; Quyyumi AA; Sperling L
    Atherosclerosis; 2018 Sep; 276():1-9. PubMed ID: 30006321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for cardiovascular disease.
    Lutgens E; Atzler D; Döring Y; Duchene J; Steffens S; Weber C
    Eur Heart J; 2019 Dec; 40(48):3937-3946. PubMed ID: 31121017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients.
    Muhlestein JB
    Thromb Haemost; 2010 Jan; 103(1):71-82. PubMed ID: 20062914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?
    Ridker PM
    Cardiovasc Res; 2021 Sep; 117(11):e138-e140. PubMed ID: 34352102
    [No Abstract]   [Full Text] [Related]  

  • 10. Interplay between inflammation and thrombosis in cardiovascular pathology.
    Stark K; Massberg S
    Nat Rev Cardiol; 2021 Sep; 18(9):666-682. PubMed ID: 33958774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial: update on inflammatory targets modulating atherogenesis.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and atherosclerosis: fulfilling Koch's postulates.
    Jialal I; Vikram NK
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):5-6. PubMed ID: 29187060
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic inflammation and atherosclerosis].
    von Hundelshausen P; Weber C
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1839-44. PubMed ID: 24006166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines as therapeutic targets for cardio- and cerebrovascular diseases.
    Liberale L; Ministrini S; Carbone F; Camici GG; Montecucco F
    Basic Res Cardiol; 2021 Mar; 116(1):23. PubMed ID: 33770265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Notch Signaling Pathway in Chronic Inflammatory Diseases.
    Christopoulos PF; Gjølberg TT; Krüger S; Haraldsen G; Andersen JT; Sundlisæter E
    Front Immunol; 2021; 12():668207. PubMed ID: 33912195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines.
    Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week.
    Ridker PM
    J Am Coll Cardiol; 2018 Dec; 72(25):3320-3331. PubMed ID: 30415883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine Circuits in Cardiovascular Disease.
    Williams JW; Huang LH; Randolph GJ
    Immunity; 2019 Apr; 50(4):941-954. PubMed ID: 30995508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.